Status:
COMPLETED
Patient Factors Impacting Adherence to Oral Chemotherapy
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Breast Cancer
Gastrointestinal Cancer
Eligibility:
All Genders
21+ years
Brief Summary
The purpose of this study is to identify what makes it easier and what makes it harder to take oral chemotherapy.
Eligibility Criteria
Inclusion
- Diagnosis of primary breast cancer or gastrointestinal cancer
- Currently prescribed capecitabine
- Age 21 years or older
- Able to understand written and oral English
Exclusion
- Major psychopathology or cognitive impairment likely in the judgment of the research staff to interfere with the participation or completion of the protocol.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT01487343
Start Date
November 1 2011
End Date
November 1 2016
Last Update
November 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065